JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BELLIS, C. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by BELLIS, C. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 50, Issue 1, 21-27, 1934
Copyright © 1934 by American Society for Pharmacology and Experimental Therapeutics


EFFECT OF CYANIDE ON PRIMARY MUSCLE TYPES

CARROLL J. BELLIS 1

1 Department of Physiology, University of Minnesota Medical School, Minneapolis, Minnesota

Skeletal muscle of the frog after the administration of cyanide showed little change in the curve of contraction other than a slight lengthening of the contraction phase. The contraction curve of the artificially stimulated rectal muscle, however, showed slow relaxation after cyanide, while the latent and contraction periods were shortened. The frog heart was immediately killed by intraventricular injection of cyanide, while the turtle heart was stimulated by the same dose. The perfused rabbit heart was at first stimulated by the cyanide and then ceased to beat and passed into a condition of extreme rigor. Although the heart beat was decreasing, temporary revival could be obtained by the addition of glutathione or epinephrine to the perfusate, but this effect was finally lost.

Submitted on May 15, 1933







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1934 by the American Society for Pharmacology and Experimental Therapeutics.